News
9h
Explícame on MSNFDA Alert: Two Medications Withdrawn from Market Due to Health RisksThe FDA plays a crucial role in safeguarding public health by monitoring the safety of products. Recently, two significant ...
The Food and Drug Administration has updated their recall of a batch of Dubai chocolate spread to Class I, their highest ...
14h
Econostrum on MSNIce Cream Recall: FDA Issues Risk Warning for Contaminated Products in 23 StatesThe U.S. Food and Drug Administration (FDA) has announced a Class II risk warning for a widespread recall of ice cream ...
Lewis Bake Shop is issuing a voluntary recall on their Artisanal Style 1/2 Loaf, which contains undisclosed hazelnuts — a ...
From May to November 2020, the FDA asked at least six companies to voluntarily recall several lots of extended-release metformin after agency lab testing revealed unacceptable levels of NDMA.
Viona Pharmaceuticals yanked 750 mg Metformin Hydrochloride Extended-Release Tablets after some tested as having too much cancer-causing ingredient NDMA.
The latest recall of type 2 diabetes drug metformin was made Friday by Viola Pharmaceuticals, which pulled two lots of 750 mg tablets.
Viona Pharmaceuticals Inc., is voluntarily recalling 2 (two) lots of Metformin Hydrochloride Extended-Release Tablets, USP 750 mg to the retail level. View full recall details at FDA.gov 12,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results